NOT-NS-22-120: Notice of Correction to Announcement Type for "PAR-22-142: NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)"

Notice of Correction to Announcement Type for "PAR-22-142: NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)"

Notice Number:

NOT-NS-22-120

Key Dates

Release Date:

July 28, 2022

Related Announcements

PAR-22-142: NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)

PAR-21-236: NINDS Exploratory Clinical Trials (U01 - Clinical Trial Required)

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this Notice is to correct the Announcement Type in PAR-22-142 "NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)". This Funding Opportunity Announcement (FOA) erroneously listed the Announcement type as "New". This has been corrected to show PAR-22-142 is a reissue of "PAR-21-236: NINDS Exploratory Clinical Trials (U01 - Clinical Trial Required)".

Currently Reads:

Part 1. Overview Information

Announcement Type - New

Revised to Read (changed in bold italics):

Part 1. Overview Information

Announcement Type - Reissue of PAR-21-236

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Jeremy Brown MD
National Institute for Neurological Diorders and Stroke (NINDS)
[email protected]